Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myopathy: Recent Progress, Current Therapies, and Future Directions.

Literature DB >> 30443717

Myopathy: Recent Progress, Current Therapies, and Future Directions.

Andrew L Mammen^1,2,3, Ricardo H Roda⁴, Doris G Leung^4,5.

Abstract

Entities: Disease

Mesh：

Year: 2018 PMID： 30443717 PMCID： PMC6277290 DOI： 10.1007/s13311-018-00688-y

Source DB: PubMed Journal: Neurotherapeutics ISSN： 1878-7479 Impact factor: 7.620

Keyword Cloud
References

× No keyword cloud information.

14 in total

Review 1. Myopathies Related to Glycogen Metabolism Disorders.

Authors: Mark A Tarnopolsky
Journal: Neurotherapeutics Date: 2018-10 Impact factor: 7.620

Review 2. Pompe Disease: From Basic Science to Therapy.

Authors: Lara Kohler; Rosa Puertollano; Nina Raben
Journal: Neurotherapeutics Date: 2018-10 Impact factor: 7.620

Review 3. Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy.

Authors: Perry B Shieh
Journal: Neurotherapeutics Date: 2018-10 Impact factor: 7.620

4. Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors: E P Hoffman; R H Brown; L M Kunkel
Journal: Cell Date: 1987-12-24 Impact factor: 41.582

5. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations.

Authors: Eunju Kang; Jun Wu; Nuria Marti Gutierrez; Amy Koski; Rebecca Tippner-Hedges; Karen Agaronyan; Aida Platero-Luengo; Paloma Martinez-Redondo; Hong Ma; Yeonmi Lee; Tomonari Hayama; Crystal Van Dyken; Xinjian Wang; Shiyu Luo; Riffat Ahmed; Ying Li; Dongmei Ji; Refik Kayali; Cengiz Cinnioglu; Susan Olson; Jeffrey Jensen; David Battaglia; David Lee; Diana Wu; Taosheng Huang; Don P Wolf; Dmitry Temiakov; Juan Carlos Izpisua Belmonte; Paula Amato; Shoukhrat Mitalipov
Journal: Nature Date: 2016-11-30 Impact factor: 49.962

Myopathy: Recent Progress, Current Therapies, and Future Directions.

Review 1. Myopathies Related to Glycogen Metabolism Disorders.

Review 2. Pompe Disease: From Basic Science to Therapy.

Review 3. Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy.

4. Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

5. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations.

Review 6. Autoimmune Myopathies: Updates on Evaluation and Treatment.

Review 7. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.

Review 8. The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon?

Review 9. Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.

Review 10. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.